The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Spero Therapeutics, Inc(NASDAQ:SPRO) 
Spero Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on identifying, developing, and commercializing novel treatments for multi-drug resistant (MDR) bacterial infections and rare diseases in the United States. Its product candidates include tebipenem pivoxil hydrobromide (HB...
Website: http://sperotherapeutics.com
Founded: 2013
Full Time Employees: 57
Sector: Healthcare
Industry: Biotechnology
Spero Therapeutics Days Payable Outstanding ttm (DPO)
Spero Therapeutics Days Receivable Outstanding ttm (DSO)
Spero Therapeutics Op Cashflow Per Share ttm
Spero Therapeutics Free Cashflow Per Share ttm
Spero Therapeutics Cash Per Share ttm
Spero Therapeutics P/S ratio ttm
Spero Therapeutics (GAAP) P/E ratio ttm
Spero Therapeutics P/B ratio ttm
No extra charts and metrics for this ticker.